Aspen Pharmacare Holdings (JSE:APN) Forward Dividend Yield %: 1.36% (As of Jun. 29, 2026)


JSE:APN Aspen Pharmacare Holdings Ltd JSE:APN
73 GF Score
Price R154.85
GF Value R178.17
Valuation Modestly Undervalued
! 10 Warning Signs
View Full Analysis

What is Aspen Pharmacare Holdings Forward Dividend Yield %?

Aspen Pharmacare Holdings JSE:APN +0.66% 73 Forward Dividend Yield % is 1.36% as of Jun. 29, 2026. GuruFocus rates JSE:APN with a GF Score™ of 73/100 and a GF Value™ of R178.17 (Modestly Undervalued). The stock has 10 warning signs investors should review. Among 505 Drug Manufacturers companies, Aspen Pharmacare Holdings ranks worse than 64.75% on this metric.

As of today (2026-06-29), the Forward Annual Dividend Yield of Aspen Pharmacare Holdings is 1.36%.

As of today (2026-06-29), the Trailing Annual Dividend Yield of Aspen Pharmacare Holdings is 1.36%.

JSE:APN's Forward Dividend Yield % is ranked worse than
64.75% of 505 companies
in the Drug Manufacturers industry
Industry Median: 2.08 vs JSE:APN: 1.36

Aspen Pharmacare Holdings's Dividends per Share for the six months ended in Dec. 2025 was R2.11.

During the past 12 months, Aspen Pharmacare Holdings's average Dividends Per Share Growth Rate was -41.20% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 11.10% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Aspen Pharmacare Holdings was 63.40% per year. The lowest was -6.00% per year. And the median was 18.25% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Aspen Pharmacare Holdings  (JSE:APN) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Aspen Pharmacare Holdings Forward Dividend Yield % Related Terms


JSE:APN vs ZTS, UTHR, VTRS: Forward Dividend Yield % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Aspen Pharmacare Holdings's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aspen Pharmacare Holdings Forward Dividend Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aspen Pharmacare Holdings's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Aspen Pharmacare Holdings's Forward Dividend Yield % falls into.


JSE:APN
73GF Score
Aspen Pharmacare Holdings Ltd JSE:APN
Forward Dividend Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aspen Pharmacare Holdings Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Aspen Pharmacare Holdings Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
ZAR 2.1100002025-10-012025-10-032025-10-06Cash DividendannuallyZAR:ZAR 1.000000

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

Aspen Pharmacare Holdings's Forward Annual Dividend Yield (%) for Today is calculated as

Forward Annual Dividend Yield=Forward Full Year Dividend/Current Share Price
=2.11/154.85
=1.36 %

Current Share Price is R154.85.
Aspen Pharmacare Holdings's Dividends per Share for the forward twelve months is calculated as R2.11 * 1 = R2.11.

Aspen Pharmacare Holdings's Trailing Annual Dividend Yield (%) for Today is calculated as

Trailing Annual Dividend Yield=Most Recent Full Year Dividend/Current Share Price
=2.11/154.85
=1.36 %

Current Share Price is R154.85.
Aspen Pharmacare Holdings's Dividends per Share for the trailing twelve months (TTM) ended in Today is R2.11.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Forward Dividend Yield % of 1.36% mean?
Aspen Pharmacare Holdings (JSE:APN) has a Forward Dividend Yield % of 1.36% as of Jun. 29, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Aspen Pharmacare Holdings and its competitors. According to the industry distribution chart, Aspen Pharmacare Holdings ranks #327 out of 505 companies in the Drug Manufacturers industry, placing it in the top 64.8%.
Is Aspen Pharmacare Holdings' Forward Dividend Yield % too high?
Aspen Pharmacare Holdings' current Forward Dividend Yield % is 1.36%. The Drug Manufacturers industry median Forward Dividend Yield % is 2.08. Aspen Pharmacare Holdings' value of 1.36% is 34.6% below this industry median. Based on the distribution chart, Aspen Pharmacare Holdings ranks #327 out of 505 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Aspen Pharmacare Holdings has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Aspen Pharmacare Holdings' Forward Dividend Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Aspen Pharmacare Holdings ranks #327 out of 505 companies for Forward Dividend Yield %. This places Aspen Pharmacare Holdings in the lower half of its industry. The industry median Forward Dividend Yield % is 2.08. Aspen Pharmacare Holdings' value of 1.36% is 34.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Drug Manufacturers company?
The median Forward Dividend Yield % among Drug Manufacturers companies is 2.08, based on 505 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aspen Pharmacare Holdings's current Forward Dividend Yield % of 1.36% is 34.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Aspen Pharmacare Holdings and its competitors. For the Drug Manufacturers industry, the median Forward Dividend Yield % is 2.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aspen Pharmacare Holdings's current Forward Dividend Yield % is 1.36%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aspen Pharmacare Holdings stock overvalued right now?
Based on GuruFocus' analysis, Aspen Pharmacare Holdings (JSE:APN) is currently considered Modestly Undervalued. The stock's GF Value™ is R178.17, compared to a current price of R154.85 — trading 13.1% below its estimated fair value. The current Forward Dividend Yield % is 1.36% and 34.6% below the Drug Manufacturers industry median of 2.08. Aspen Pharmacare Holdings' overall GF Score™ is 73/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Aspen Pharmacare Holdings (JSE:APN), the current Forward Dividend Yield % is 1.36% as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Aspen Pharmacare Holdings (JSE:APN) Overvalued in 2026?

Based on GuruFocus' analysis, Aspen Pharmacare Holdings stock appears to be undervalued. The current stock price of R154.85 is trading 13.1% below its estimated GF Value™ of R178.17. GuruFocus considers Aspen Pharmacare Holdings to be Modestly Undervalued.

Key valuation signals for JSE:APN:

  • Forward Dividend Yield %: 1.36%
  • GF Value™: R178.17 vs. price of R154.85 (13.1% below fair value)
  • GF Score™: 73/100 with 10 warning signs
  • Industry Position: 34.6% below the Drug Manufacturers median (#327 of 505)

No single metric tells the full story. See the JSE:APN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Aspen Pharmacare Holdings Business Description

Address Douglas Saunders Drive, Aspen Place, 9 Rydall Vale Park, La Lucia Ridge, Durban, NL, ZAF
Aspen Pharmacare Holdings Ltd is a multinational pharmaceutical company. The group focuses on marketing and manufacturing a broad range of post-patent, branded medicines and domestic brands covering both hospital and consumer markets. The business segments of the group are split between the Commercial Pharmaceuticals and Manufacturing segments. The Commercial Pharmaceuticals business segments are: Injectables, Over-the-counter, and Prescription. The Manufacturing business segments are: Active Pharmaceutical Ingredients, Finished Dose Form, and Heparin. Its geographic regions are Africa Middle East, Europe CIS, Australasia, Asia, and America.
73GF Score

Get the complete analysis for JSE:APN

Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R154.85
Price
R178.17
GF Value